Drag

Aurobindo Pharma

Healthcare NSE:AUROPHARMA

1231.90INR
6.40 ( 0.52%)

Last update at March 6, 2026, midnight

Day Range

1215.101244.70
LowHigh

52 Week Range

1006.22 1273.82
LowHigh

Fundamentals

  • Previous Close 1225.50
  • Market Cap 700504.80M
  • Volume804,367
  • P/E Ratio 20.47
  • EBITDA 65321.60M
  • Revenue TTM 325144.81M
  • Revenue Per Share TTM 559.82
  • Gross Profit TTM 187354.91M
  • Diluted EPS TTM 58.93

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 50662.90M 43799.90M 26125.00M 33727.40M 73435.90M
Net income 34858.80M 31729.70M 19275.00M 26481.50M 53348.40M
Total Revenue 317237.30M 290018.70M 246171.30M 233665.50M 245579.40M
Gross Profit 182398.70M 160161.80M 133238.70M 132262.70M 146554.70M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 497849.70M 450715.10M 398899.90M 339217.20M 338539.90M
Intangible assets 36207.00M 34814.60M 33258.50M 31378.70M 26907.00M
Other current assets 26217.50M 32554.90M 18687.00M 15550.10M 14488.10M
Deferred long term liab - - - 1791.60M 1361.00M
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 21783.60M -10068.40M 2297.60M -11674.00M 25830.90M
Operating Cash 39246.20M 24345.20M 23867.50M 50164.80M 33289.20M
Free Cash Flow 19567.60M -11269.80M -3336.50M 23118.40M 14551.10M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
AUROPHARMA
Aurobindo Pharma 		6.40 0.52% 1231.90 700504.80 20.47
SUNPHARMA
Sun Pharmaceutical Industries Limited 		14.90 0.84% 1799.40 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-35.50 -0.56% 6329.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-35.60 -0.82% 4317.80 1362716.66 63.48
CIPLA
Cipla Limited 		-5.20 -0.39% 1321.20 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.